Multiple Sclerosis and Related Disorders Journal Citation Rate 2026

ISSN 2211-0348 eISSN 2211-0356 Elsevier BV NL

Q2 Quartile Established Impact

About Multiple Sclerosis and Related Disorders

Multiple Sclerosis and Related Disorders (MSRD) is a peer-reviewed academic journal, published by Elsevier BV in NL. It is catalogued under ISSN 2211-0348 (electronic ISSN 2211-0356).

Multiple Sclerosis and Related Disorders Citation Rate 2026 — In Context

Multiple Sclerosis and Related Disorders has a 2025 2-Year Citation Rate (OpenAlex) of 2.02, placing it in the Q2 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not a OpenAlex Journal Impact Factor.

Multiple Sclerosis and Related Disorders operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Multiple Sclerosis and Related Disorders should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Multiple Sclerosis and Related Disorders against similar journals in the field, use our journal comparison tool.

Submission Tips for Multiple Sclerosis and Related Disorders
  • Budget $3020 for the Article Processing Charge. Check if your institution or funder covers OA fees.
ISSN (Print) 2211-0348
ISSN (Online) 2211-0356
Publisher Elsevier BV
Country Netherlands
APC / Cost $3020 USD
In-depth profile & metrics

Multiple Sclerosis and Related Disorders is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 3020.

Multiple Sclerosis and Related Disorders is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.020.

Links
Frequently Asked Questions about Multiple Sclerosis and Related Disorders

The current impact factor of Multiple Sclerosis and Related Disorders is 2.020.

No, Multiple Sclerosis and Related Disorders is not an open access journal.

The Article Processing Charge (APC) for Multiple Sclerosis and Related Disorders is $3020 USD.

Multiple Sclerosis and Related Disorders is published by Elsevier BV.

Multiple Sclerosis and Related Disorders shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Multiple Sclerosis and Related Disorders is 2211-0348. Its electronic ISSN (eISSN) is 2211-0356.

Multiple Sclerosis and Related Disorders sits in the Q2 quartile based on its latest impact factor of 2.02, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
2.020
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.020 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S2764622253

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google